Skip to main content
Erschienen in: Reviews in Endocrine and Metabolic Disorders 4/2018

15.06.2018

Thyroid diseases and skin autoimmunity

verfasst von: Enke Baldini, Teresa Odorisio, Chiara Tuccilli, Severino Persechino, Salvatore Sorrenti, Antonio Catania, Daniele Pironi, Giovanni Carbotta, Laura Giacomelli, Stefano Arcieri, Massimo Vergine, Massimo Monti, Salvatore Ulisse

Erschienen in: Reviews in Endocrine and Metabolic Disorders | Ausgabe 4/2018

Einloggen, um Zugang zu erhalten

Abstract

The skin is the largest organ of the body, at the boundary with the outside environment. Primarily, it provides a physical and chemical barrier against external insults, but it can act also as immune organ because it contains a whole host of immune-competent cells of both the innate and the adaptive immune systems, which cooperate in eliminating invading pathogens following tissue injury. On the other hand, improper skin immune responses lead to autoimmune skin diseases (AISD), such as pemphigus, bullous pemphigoid, vitiligo, and alopecia. Although the interplay among genetic, epigenetic, and environmental factors has been shown to play a major role in AISD etiology and progression, the molecular mechanisms underlying disease development are far from being fully elucidated. In this context, epidemiological studies aimed at defining the association of different AISD with other autoimmune pathologies revealed possible shared molecular mechanism(s) responsible for disease progression. In particular, over the last decades, a number of reports have highlighted a significant association between thyroid diseases (TD), mainly autoimmune ones (AITD), and AISD. Here, we will recapitulate the epidemiology, clinical manifestations, and pathogenesis of the main AISD, and we will summarize the epidemiological evidence showing the associations with TD as well as possible molecular mechanism(s) underlying TD and AISD pathological manifestations.
Literatur
2.
Zurück zum Zitat Paschke R. Molecular pathogenesis of nodular goiter. Langenbecks Arch Surg. 2011;396:1127–36.CrossRefPubMed Paschke R. Molecular pathogenesis of nodular goiter. Langenbecks Arch Surg. 2011;396:1127–36.CrossRefPubMed
3.
Zurück zum Zitat Yoo WS, Chung HK. Recent advances in autoimmune thyroid diseases. Endocrinol Metab. 2016;31:379–85.CrossRef Yoo WS, Chung HK. Recent advances in autoimmune thyroid diseases. Endocrinol Metab. 2016;31:379–85.CrossRef
4.
Zurück zum Zitat Stassi G, De Maria R. Autoimmune thyroid disease: new model of cell death in autoimmunity. Nat Rev Immunol. 2003;2:195–204.CrossRef Stassi G, De Maria R. Autoimmune thyroid disease: new model of cell death in autoimmunity. Nat Rev Immunol. 2003;2:195–204.CrossRef
5.
Zurück zum Zitat Gharib M, Gharib H. Guidelines for the diagnosis and management of thyroid nodules. Thyroid Int. 2011;1:3–11. Gharib M, Gharib H. Guidelines for the diagnosis and management of thyroid nodules. Thyroid Int. 2011;1:3–11.
6.
Zurück zum Zitat Nikiforov YE, Biddinger PW, Thompson LDR. Diagnostic pathology and molecular genetics of the thyroid. Philadelphia: Wolters Kluwer – Lippincott Williams & Wilkins; 2009. Nikiforov YE, Biddinger PW, Thompson LDR. Diagnostic pathology and molecular genetics of the thyroid. Philadelphia: Wolters Kluwer – Lippincott Williams & Wilkins; 2009.
7.
Zurück zum Zitat Antonelli A, Ferrari SM, Corrado A, Di Domenicantonio A, Fallahi P. Autoimmune thyroid disorders. Autoimmun Rev. 2015;14:174–80.CrossRefPubMed Antonelli A, Ferrari SM, Corrado A, Di Domenicantonio A, Fallahi P. Autoimmune thyroid disorders. Autoimmun Rev. 2015;14:174–80.CrossRefPubMed
9.
Zurück zum Zitat Shukla SK, Singh G, Ahmad S, Pant P. Infections, genetic and environmental factors in pathogenesis of autoimmune thyroid diseases. Microb Pathog. 2018;116:279–88.CrossRefPubMed Shukla SK, Singh G, Ahmad S, Pant P. Infections, genetic and environmental factors in pathogenesis of autoimmune thyroid diseases. Microb Pathog. 2018;116:279–88.CrossRefPubMed
10.
Zurück zum Zitat Ajjan RA, Weetman AP. The pathogenesis of Hashimoto’s thyroiditis: further developments in our understanding. Horm Metab Res. 2015;47:702–10.CrossRefPubMed Ajjan RA, Weetman AP. The pathogenesis of Hashimoto’s thyroiditis: further developments in our understanding. Horm Metab Res. 2015;47:702–10.CrossRefPubMed
11.
Zurück zum Zitat Brix TH, Kyvik KO, Hegedus L. A population-based study of chronic autoimmune hypothyroidism in Danish twins. J Clin Endocrinol Metab. 2000;85:536–9.PubMed Brix TH, Kyvik KO, Hegedus L. A population-based study of chronic autoimmune hypothyroidism in Danish twins. J Clin Endocrinol Metab. 2000;85:536–9.PubMed
13.
Zurück zum Zitat Vaccaro M, Guarneri F, Borgia F, Cannavò SP, Benvenga S. Association of lichen sclerosus and autoimmune thyroiditis: possible role of Borrelia burgdorferi? Thyroid. 2002;12:1147–8.CrossRefPubMed Vaccaro M, Guarneri F, Borgia F, Cannavò SP, Benvenga S. Association of lichen sclerosus and autoimmune thyroiditis: possible role of Borrelia burgdorferi? Thyroid. 2002;12:1147–8.CrossRefPubMed
14.
Zurück zum Zitat Benvenga S, Guarneri F. Molecular mimicry and autoimmune thyroid disease. Rev Endocr Metab Disord. 2016;17:485–98.CrossRefPubMed Benvenga S, Guarneri F. Molecular mimicry and autoimmune thyroid disease. Rev Endocr Metab Disord. 2016;17:485–98.CrossRefPubMed
15.
Zurück zum Zitat Proksch E, Brandner JM, Jensen JM. The skin: an indispensable barrier. Exp Dermatol. 2008;17:1063–72.CrossRefPubMed Proksch E, Brandner JM, Jensen JM. The skin: an indispensable barrier. Exp Dermatol. 2008;17:1063–72.CrossRefPubMed
16.
Zurück zum Zitat Cichorek M, Wachulska M, Stasiewicz A, Tymińska A. Skin melanocytes: biology and development. Postepy Dermatol Alergol. 2013:30:30–41. Cichorek M, Wachulska M, Stasiewicz A, Tymińska A. Skin melanocytes: biology and development. Postepy Dermatol Alergol. 2013:30:30–41.
18.
19.
Zurück zum Zitat Sriram G, Bigliardi PL, Bigliardi-Qi M. Fibroblast heterogeneity and its implications for engineering organotypic skin models in vitro. Eur J Cell Biol. 2015;94:483–512.CrossRefPubMed Sriram G, Bigliardi PL, Bigliardi-Qi M. Fibroblast heterogeneity and its implications for engineering organotypic skin models in vitro. Eur J Cell Biol. 2015;94:483–512.CrossRefPubMed
20.
Zurück zum Zitat Brohem CA, Cardeal LB, Tiago M, Soengas MS, Barros SB, Maria-Engler SS. Artificial skin in perspective: concepts and applications. Pigment Cell Melanoma Res. 2011;24:35–50.CrossRefPubMed Brohem CA, Cardeal LB, Tiago M, Soengas MS, Barros SB, Maria-Engler SS. Artificial skin in perspective: concepts and applications. Pigment Cell Melanoma Res. 2011;24:35–50.CrossRefPubMed
21.
Zurück zum Zitat Martel JL, Badri T. Anatomy, Head, Hair, Follicle. StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2018 Jan-2018 Jan 10.) Martel JL, Badri T. Anatomy, Head, Hair, Follicle. StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2018 Jan-2018 Jan 10.)
23.
Zurück zum Zitat Ávalos-Díaz E, Herrera Esparza R. Dermatological autoimmune diseases. In: Anaya JM, Shoenfeld Y, Rojas-Villarraga A, Levy RA, Cervera R, editors. Autoimmunity: From Bench to Bedside. Bogota: El Rosario: University Press; 2013. p. 597–610. Ávalos-Díaz E, Herrera Esparza R. Dermatological autoimmune diseases. In: Anaya JM, Shoenfeld Y, Rojas-Villarraga A, Levy RA, Cervera R, editors. Autoimmunity: From Bench to Bedside. Bogota: El Rosario: University Press; 2013. p. 597–610.
25.
Zurück zum Zitat Bruserud Ø, Oftedal BE, Wolff AB, Husebye ES. AIRE-mutations and autoimmune disease. Curr Opin Immunol. 2016;43:8–15.CrossRefPubMed Bruserud Ø, Oftedal BE, Wolff AB, Husebye ES. AIRE-mutations and autoimmune disease. Curr Opin Immunol. 2016;43:8–15.CrossRefPubMed
26.
Zurück zum Zitat Michels AW, Gottlieb PA. Autoimmune polyglandular syndromes. Nat Rev Endocrinol. 2010;6:270–7.CrossRefPubMed Michels AW, Gottlieb PA. Autoimmune polyglandular syndromes. Nat Rev Endocrinol. 2010;6:270–7.CrossRefPubMed
27.
Zurück zum Zitat Kahaly GJ, Frommer L. Polyglandular autoimmune syndromes. J Endocrinol Invest. 2018;41:91–8.CrossRefPubMed Kahaly GJ, Frommer L. Polyglandular autoimmune syndromes. J Endocrinol Invest. 2018;41:91–8.CrossRefPubMed
28.
Zurück zum Zitat Obermayer-Straub P, Manns MP. Autoimmune polyglandular syndromes. Baillieres Clin Grastroenterol. 1998;12:293–315.CrossRef Obermayer-Straub P, Manns MP. Autoimmune polyglandular syndromes. Baillieres Clin Grastroenterol. 1998;12:293–315.CrossRef
29.
Zurück zum Zitat Betterle C, Zanchetta R. Update on autoimmune polymdocrine syndromes (APS). Acta Biomed. 2003;74:9–33.PubMed Betterle C, Zanchetta R. Update on autoimmune polymdocrine syndromes (APS). Acta Biomed. 2003;74:9–33.PubMed
30.
Zurück zum Zitat Sheehan MT, Islam R. Silent thyroiditis, isolated corticotropin deficiency, and alopecia universalis in a patient with ulcerative colitis and elevated levels of plasma factor VIII: an unusual case of autoimmune polyglandular syndrome type 3. Endocr Pract. 2009;15:138–42.CrossRefPubMed Sheehan MT, Islam R. Silent thyroiditis, isolated corticotropin deficiency, and alopecia universalis in a patient with ulcerative colitis and elevated levels of plasma factor VIII: an unusual case of autoimmune polyglandular syndrome type 3. Endocr Pract. 2009;15:138–42.CrossRefPubMed
31.
Zurück zum Zitat Di Zenzo G, Della Torre R, Zambruno G, Borradori L. Bullous pemphigoid: from the clinic to the bench. Clin Dermatol. 2012;30:3–16.CrossRefPubMed Di Zenzo G, Della Torre R, Zambruno G, Borradori L. Bullous pemphigoid: from the clinic to the bench. Clin Dermatol. 2012;30:3–16.CrossRefPubMed
32.
Zurück zum Zitat Cozzani E, Gasparini G, Burlando M, Drago F, Parodi A. Atypical presentations of bullous pemphigoid: Clinical and immunopathological aspects. Autoimmun Rev. 2015;14:438–45.CrossRefPubMed Cozzani E, Gasparini G, Burlando M, Drago F, Parodi A. Atypical presentations of bullous pemphigoid: Clinical and immunopathological aspects. Autoimmun Rev. 2015;14:438–45.CrossRefPubMed
34.
Zurück zum Zitat Roujeau J-C, Lok C, Bastuji-Garin S, Mhalla S, Enginger V, Bernard P. High risk of death in elderly patients with extensive bullous pemphigoid. Arch Dermatol. 1998;134:465–9.CrossRefPubMed Roujeau J-C, Lok C, Bastuji-Garin S, Mhalla S, Enginger V, Bernard P. High risk of death in elderly patients with extensive bullous pemphigoid. Arch Dermatol. 1998;134:465–9.CrossRefPubMed
35.
Zurück zum Zitat Colbert RL, Allen DM, Eastwood D, Fairley JA. Mortality rate of bullous pemphigoid in a US Medical Center. J Incest Dermatol. 2004;122:1091–5.CrossRef Colbert RL, Allen DM, Eastwood D, Fairley JA. Mortality rate of bullous pemphigoid in a US Medical Center. J Incest Dermatol. 2004;122:1091–5.CrossRef
36.
Zurück zum Zitat Jonkman MF, de Jong MC, Heeres K, Pas HH, van der Meer JB, Owaribe K, et al. 180-kD bullous pemphigoid antigen (BP180) is deficient in generalized atrophic benign epidermolysis bullosa. J Clin Invest. 1995;95:1345–52. Jonkman MF, de Jong MC, Heeres K, Pas HH, van der Meer JB, Owaribe K, et al. 180-kD bullous pemphigoid antigen (BP180) is deficient in generalized atrophic benign epidermolysis bullosa. J Clin Invest. 1995;95:1345–52.
37.
Zurück zum Zitat Groves RW, Liu L, Dopping-Hepenstal PJ, Markus HS, Lovell PA, Ozoemena L, et al. A homozygous nonsense mutation within the dystonin gene coding for the coiled-coil domain of the epithelial isoform of BPAG1 underlies a new subtype of autosomal recessive epidermolysis bullosa simplex. J Invest Dermatol. 2010;130:1551–7. Groves RW, Liu L, Dopping-Hepenstal PJ, Markus HS, Lovell PA, Ozoemena L, et al. A homozygous nonsense mutation within the dystonin gene coding for the coiled-coil domain of the epithelial isoform of BPAG1 underlies a new subtype of autosomal recessive epidermolysis bullosa simplex. J Invest Dermatol. 2010;130:1551–7.
38.
Zurück zum Zitat Büdinger L, Borradori L, Yee C, Eming R, Ferencik S, Grosse-Wilde H, et al. Identification and characterization of autoreactive T cell responses to bullous pemphigoid antigen 2 in patients and healthy controls. J Clin Invest. 1998;102:2082–9. Büdinger L, Borradori L, Yee C, Eming R, Ferencik S, Grosse-Wilde H, et al. Identification and characterization of autoreactive T cell responses to bullous pemphigoid antigen 2 in patients and healthy controls. J Clin Invest. 1998;102:2082–9.
39.
Zurück zum Zitat Delgado JC, Turbay D, Yunis EJ, Yunis JJ, Morton ED, Bhol K, et al. A common major histocompatibility complex class II allele HLA-DQB1* 0301 is present in clinical variants of pemphigoid. Proc Natl Acad Sci U S A. 1996;93:8569–71. Delgado JC, Turbay D, Yunis EJ, Yunis JJ, Morton ED, Bhol K, et al. A common major histocompatibility complex class II allele HLA-DQB1* 0301 is present in clinical variants of pemphigoid. Proc Natl Acad Sci U S A. 1996;93:8569–71.
40.
Zurück zum Zitat Bastuji-Garin S, Joly P, Picard-Dahan C, Bernard P, Vaillant L, Pauwels C, et al. Drugs associated with bullous pemphigoid. A case-control study. Arch Dermatol. 1996;132:272–6. Bastuji-Garin S, Joly P, Picard-Dahan C, Bernard P, Vaillant L, Pauwels C, et al. Drugs associated with bullous pemphigoid. A case-control study. Arch Dermatol. 1996;132:272–6.
41.
Zurück zum Zitat Bastuji-Garin S, Joly P, Lemordant P, Sparsa A, Bedane C, Delaporte E, et al. Ingen-Housz-Oro S, Maillard H, Pauwels C, Picard-Dahan C, Dutronc Y, Richard MA; French Study Group for Bullous Diseases. Risk factors for bullous pemphigoid in the elderly: a prospective case-control study. J Invest Dermatol. 2011;131:637–43. Bastuji-Garin S, Joly P, Lemordant P, Sparsa A, Bedane C, Delaporte E, et al. Ingen-Housz-Oro S, Maillard H, Pauwels C, Picard-Dahan C, Dutronc Y, Richard MA; French Study Group for Bullous Diseases. Risk factors for bullous pemphigoid in the elderly: a prospective case-control study. J Invest Dermatol. 2011;131:637–43.
42.
Zurück zum Zitat Ljubojevic S, Lipozenčić J. Autoimmune bullous diseases associations. Clin Dermatol. 2012;30:17–33.CrossRefPubMed Ljubojevic S, Lipozenčić J. Autoimmune bullous diseases associations. Clin Dermatol. 2012;30:17–33.CrossRefPubMed
43.
Zurück zum Zitat Callen JP, McCall MW. Bullous pemphigoid and Hashimoto’s thyroiditis. J am Acad Dermatol. 1981;5:558–60.CrossRefPubMed Callen JP, McCall MW. Bullous pemphigoid and Hashimoto’s thyroiditis. J am Acad Dermatol. 1981;5:558–60.CrossRefPubMed
44.
Zurück zum Zitat Fiorucci MC, Cozzani E, Casu M, Murialdo G, Parodi A, Rebora A. Bullous pemphigoid and Graves' disease: an association between skin and thyroid autoimmunity. Acta Derm Venereol. 2005;85:560–1.PubMed Fiorucci MC, Cozzani E, Casu M, Murialdo G, Parodi A, Rebora A. Bullous pemphigoid and Graves' disease: an association between skin and thyroid autoimmunity. Acta Derm Venereol. 2005;85:560–1.PubMed
45.
Zurück zum Zitat How J, Bewsher PD, Stankler L. Bullous pemphigoid, polymyalgia rheumatica and thyroid disease. Br J Dermatol. 1980;103:201–4.CrossRefPubMed How J, Bewsher PD, Stankler L. Bullous pemphigoid, polymyalgia rheumatica and thyroid disease. Br J Dermatol. 1980;103:201–4.CrossRefPubMed
46.
Zurück zum Zitat Ameri P, Cinotti E, Mussap M, Murialdo G, Parodi A, Cozzani E. Association of pemphigus and bullous pemphigoid with thyroid autoimmunity in Caucasian patients. J Am Acad Dermatol. 2013;68:687–9.CrossRefPubMed Ameri P, Cinotti E, Mussap M, Murialdo G, Parodi A, Cozzani E. Association of pemphigus and bullous pemphigoid with thyroid autoimmunity in Caucasian patients. J Am Acad Dermatol. 2013;68:687–9.CrossRefPubMed
48.
Zurück zum Zitat Schmidt E, Höpfner B, Chen M, Kuhn C, Weber L, Bröcker EB, et al. Childhood epidermolysis bullosa acquisita: a novel variant with reactivity to all three structural domains of type VII collagen. Br J Dermatol. 2002;147:592–7. Schmidt E, Höpfner B, Chen M, Kuhn C, Weber L, Bröcker EB, et al. Childhood epidermolysis bullosa acquisita: a novel variant with reactivity to all three structural domains of type VII collagen. Br J Dermatol. 2002;147:592–7.
49.
Zurück zum Zitat Chen M, Kim GH, Prakash L, Woodley DT. Epidermolysis bullosa acquisita: autoimmunity to anchoring fibril collagen. Autoimmunity. 2012;45:91–101.CrossRefPubMed Chen M, Kim GH, Prakash L, Woodley DT. Epidermolysis bullosa acquisita: autoimmunity to anchoring fibril collagen. Autoimmunity. 2012;45:91–101.CrossRefPubMed
50.
Zurück zum Zitat Roenigk HH, Ryan JG, Bergfeld WF. Epidermolysis bullosa acquisita: Report of three cases and review of all published cases. Arch Dermatol. 1971;103(1):10.CrossRef Roenigk HH, Ryan JG, Bergfeld WF. Epidermolysis bullosa acquisita: Report of three cases and review of all published cases. Arch Dermatol. 1971;103(1):10.CrossRef
51.
Zurück zum Zitat Chen M, O'Toole EA, Sanghavi J, Mahmud N, Kelleher D. Type VII collagen exists in human intestine and serves as an antigenic target in patients with inflammatory bowel disease. J Invest Dermatol. 1997;108:542. Chen M, O'Toole EA, Sanghavi J, Mahmud N, Kelleher D. Type VII collagen exists in human intestine and serves as an antigenic target in patients with inflammatory bowel disease. J Invest Dermatol. 1997;108:542.
52.
Zurück zum Zitat Oostingh GJ, Sitaru C, Zillikens D, Kromminga A, Lührs H, Kromminga A, et al. Subclass distribution of type VII collagen-specific autoantibodies in patients with inflammatory bowel disease. J Dermatol Sci. 2005;37:182–4. Oostingh GJ, Sitaru C, Zillikens D, Kromminga A, Lührs H, Kromminga A, et al. Subclass distribution of type VII collagen-specific autoantibodies in patients with inflammatory bowel disease. J Dermatol Sci. 2005;37:182–4.
53.
Zurück zum Zitat Kakar R, Paugh H, Jaworsky C. Linear IgA bullous disease presenting as toxic epidermal necrolysis: a case report and review of the literature. Dermatology. 2013;227:209–13.CrossRefPubMed Kakar R, Paugh H, Jaworsky C. Linear IgA bullous disease presenting as toxic epidermal necrolysis: a case report and review of the literature. Dermatology. 2013;227:209–13.CrossRefPubMed
54.
Zurück zum Zitat Zenke Y, Nakano T, Eto H, Koga H, Hashimoto T. A case of vancomycin-associated linear IgA bullous dermatosis and IgA antibodies to the a3 subunit of laminin-332. Br J Dermatol. 2014;170:965–9.CrossRefPubMed Zenke Y, Nakano T, Eto H, Koga H, Hashimoto T. A case of vancomycin-associated linear IgA bullous dermatosis and IgA antibodies to the a3 subunit of laminin-332. Br J Dermatol. 2014;170:965–9.CrossRefPubMed
55.
Zurück zum Zitat Tashima S, Konishi K, Koga H, Hashimoto T. A case of vancomycin-induced linear IgA bullous dermatosis with circulating IgA antibodies to the NC16a domain of BP180. Int J Dermatol. 2014;53:e207–9.CrossRefPubMed Tashima S, Konishi K, Koga H, Hashimoto T. A case of vancomycin-induced linear IgA bullous dermatosis with circulating IgA antibodies to the NC16a domain of BP180. Int J Dermatol. 2014;53:e207–9.CrossRefPubMed
57.
Zurück zum Zitat Mobacken H, Kastrup W, Ljunghall K, Löfberg H, Nilsson LA, Svensson A, et al. Linear IgA dermatosis: a study of ten adult patients. Acta Derm Venereol. 1983;63:123–8. Mobacken H, Kastrup W, Ljunghall K, Löfberg H, Nilsson LA, Svensson A, et al. Linear IgA dermatosis: a study of ten adult patients. Acta Derm Venereol. 1983;63:123–8.
58.
Zurück zum Zitat Klein PA, Callen JP. Drug-induced linear IgA bullous dermatosis after vancomycin discontinuance in a patient with renal insufficiency. J Am Acad Dermatol. 2000;42:316–23.CrossRefPubMed Klein PA, Callen JP. Drug-induced linear IgA bullous dermatosis after vancomycin discontinuance in a patient with renal insufficiency. J Am Acad Dermatol. 2000;42:316–23.CrossRefPubMed
59.
Zurück zum Zitat Pereira AR, Moura LH, Pinheiro JR, Pasin VP, Enokihara MM, Porro AM. Vancomycin-associated linear IgA disease mimicking toxic epidermal necrolysis. An Bras Dermatol. 2016;91:35–8.CrossRefPubMedPubMedCentral Pereira AR, Moura LH, Pinheiro JR, Pasin VP, Enokihara MM, Porro AM. Vancomycin-associated linear IgA disease mimicking toxic epidermal necrolysis. An Bras Dermatol. 2016;91:35–8.CrossRefPubMedPubMedCentral
60.
Zurück zum Zitat Porter WM, Hardman CM, Leonard JN, Fry L. Sarcoidosis in a patient with linear IgA disease. Clin Exp Dermatol. 1999;24:67–70.CrossRefPubMed Porter WM, Hardman CM, Leonard JN, Fry L. Sarcoidosis in a patient with linear IgA disease. Clin Exp Dermatol. 1999;24:67–70.CrossRefPubMed
61.
Zurück zum Zitat Yang JY, Park I, Kim SK. Concurrent Linear Immunoglobulin A Dermatosis, Hashimoto Thyroiditis, and Immunoglobulin A Nephropathy in an Adult. Ann Dermatol. 2017;29:226–8.CrossRefPubMedPubMedCentral Yang JY, Park I, Kim SK. Concurrent Linear Immunoglobulin A Dermatosis, Hashimoto Thyroiditis, and Immunoglobulin A Nephropathy in an Adult. Ann Dermatol. 2017;29:226–8.CrossRefPubMedPubMedCentral
62.
Zurück zum Zitat Fry L, Keir P, McMinn RM, Cowan JD, Hoffbrand AV. Small-intestinal structure and function and haematological changes in dermatitis herpetiformis. Lancet. 1967;2:729–33.CrossRefPubMed Fry L, Keir P, McMinn RM, Cowan JD, Hoffbrand AV. Small-intestinal structure and function and haematological changes in dermatitis herpetiformis. Lancet. 1967;2:729–33.CrossRefPubMed
63.
Zurück zum Zitat Reunala T, Salmi TT, Hervonen K. Dermatitis herpetiformis: pathognomonic transglutaminase IgA deposits in the skin and excellent prognosis on a gluten-free diet. Acta Derm Venereol. 2015;95:917–22.CrossRefPubMed Reunala T, Salmi TT, Hervonen K. Dermatitis herpetiformis: pathognomonic transglutaminase IgA deposits in the skin and excellent prognosis on a gluten-free diet. Acta Derm Venereol. 2015;95:917–22.CrossRefPubMed
64.
Zurück zum Zitat Reunala T, Collin P. Diseases associated with dermatitis herpetiformis. Br J Dermatol. 1997;136:315–8.CrossRefPubMed Reunala T, Collin P. Diseases associated with dermatitis herpetiformis. Br J Dermatol. 1997;136:315–8.CrossRefPubMed
65.
Zurück zum Zitat Kaplan RP, Callen JP. Dermatitis herpetiformis: autoimmune disease associations. Clin Dermatol. 1991;9:347–60.CrossRefPubMed Kaplan RP, Callen JP. Dermatitis herpetiformis: autoimmune disease associations. Clin Dermatol. 1991;9:347–60.CrossRefPubMed
66.
Zurück zum Zitat Zettinig G, Weissel M, Flores J, Dudczak R, Vogelsang H. Dermatitis herpetiformis is associated with atrophic but not with goitrous variant of Hashimoto's thyroiditis. Eur J Clin Invest. 2000;30:53–7.CrossRefPubMed Zettinig G, Weissel M, Flores J, Dudczak R, Vogelsang H. Dermatitis herpetiformis is associated with atrophic but not with goitrous variant of Hashimoto's thyroiditis. Eur J Clin Invest. 2000;30:53–7.CrossRefPubMed
67.
Zurück zum Zitat Stanley JR, Amagai M. Autoimmune bullous diseases: historical prospective. J Invest Dermatol. 2008;128:E16–8.CrossRefPubMed Stanley JR, Amagai M. Autoimmune bullous diseases: historical prospective. J Invest Dermatol. 2008;128:E16–8.CrossRefPubMed
68.
Zurück zum Zitat Anhalth GJ, Labib RS, Voorhees JJ, Beals TF, Diaz LA. Induction of pemphigus in neonatal mice by passive transfer of IgG from patients with the disease. New Engl J Med. 1982;306:1189–96.CrossRef Anhalth GJ, Labib RS, Voorhees JJ, Beals TF, Diaz LA. Induction of pemphigus in neonatal mice by passive transfer of IgG from patients with the disease. New Engl J Med. 1982;306:1189–96.CrossRef
69.
Zurück zum Zitat Zakka LR, Keskin DB, Reche P, Ahmed AR. Relationship between target antigens and major histocompatibility complex (MHC) class II genes in producing two pathogenic antibodies simultaneously. Clin Exp Immunol. 2010;162:224–36.CrossRefPubMedPubMedCentral Zakka LR, Keskin DB, Reche P, Ahmed AR. Relationship between target antigens and major histocompatibility complex (MHC) class II genes in producing two pathogenic antibodies simultaneously. Clin Exp Immunol. 2010;162:224–36.CrossRefPubMedPubMedCentral
70.
Zurück zum Zitat De Stefano GM, Christano AM. The genetics of human skin disease. Cold Spring Harb Perspect Med. 2014;4:a015172.CrossRef De Stefano GM, Christano AM. The genetics of human skin disease. Cold Spring Harb Perspect Med. 2014;4:a015172.CrossRef
71.
Zurück zum Zitat Nancy AL, Yehuda S. Prediction and prevention of autoimmune skin disorders. Arch Dermatol Res. 2009;301:57–64.CrossRefPubMed Nancy AL, Yehuda S. Prediction and prevention of autoimmune skin disorders. Arch Dermatol Res. 2009;301:57–64.CrossRefPubMed
72.
Zurück zum Zitat Callen JP. Internal disorders associated with bullous disease of the skin. A critical review. J Am Acad Dermatol. 1980;3:107–19.CrossRefPubMed Callen JP. Internal disorders associated with bullous disease of the skin. A critical review. J Am Acad Dermatol. 1980;3:107–19.CrossRefPubMed
73.
Zurück zum Zitat Heelan K, Mahar AL, Walsh S, Shear NH. Pemphigus and associated comorbidities: a cross-sectional study. Clin Exp Dermatol. 2015;40:593–9.CrossRefPubMed Heelan K, Mahar AL, Walsh S, Shear NH. Pemphigus and associated comorbidities: a cross-sectional study. Clin Exp Dermatol. 2015;40:593–9.CrossRefPubMed
74.
Zurück zum Zitat Leshem YA, Katzenelson V, Yosipovitich G, Mimouni D. Autoimmune diseases in patients with pemphigus and their first-degree relatives. Int J Dermatol. 2011;50:827–31.CrossRefPubMed Leshem YA, Katzenelson V, Yosipovitich G, Mimouni D. Autoimmune diseases in patients with pemphigus and their first-degree relatives. Int J Dermatol. 2011;50:827–31.CrossRefPubMed
75.
Zurück zum Zitat Kavala M, Kural E, Kocaturk E, Zindanci I, Turkoglu Z, Can B. The evaluation of thyroid diseases in patients with pemphigus vulgaris. Scientific World Journal. 2012;2012:146897.CrossRefPubMed Kavala M, Kural E, Kocaturk E, Zindanci I, Turkoglu Z, Can B. The evaluation of thyroid diseases in patients with pemphigus vulgaris. Scientific World Journal. 2012;2012:146897.CrossRefPubMed
76.
Zurück zum Zitat Ansar A, Farshchian M, Farahnaki S, Farshchian M. Thyroid autoimmunity in Iranian patients with pemphigus vulgaris. J Eur Acad Dermatol Venereol. 2009;23:719–20.CrossRefPubMed Ansar A, Farshchian M, Farahnaki S, Farshchian M. Thyroid autoimmunity in Iranian patients with pemphigus vulgaris. J Eur Acad Dermatol Venereol. 2009;23:719–20.CrossRefPubMed
77.
Zurück zum Zitat Pitoia F, Moncet D, Glorio R, Graciela Diaz A, Rodriguez Costa G, Carbia S, et al. Prevalence of thyroid autoimmunity in patients with pemphigus vulgaris. Medicina (B Aires). 2005;65:307–10.PubMed Pitoia F, Moncet D, Glorio R, Graciela Diaz A, Rodriguez Costa G, Carbia S, et al. Prevalence of thyroid autoimmunity in patients with pemphigus vulgaris. Medicina (B Aires). 2005;65:307–10.PubMed
78.
Zurück zum Zitat Daneshpazhooh M, Behjati J, Hashemi P, Shamohammadi S, Mortazavi H, Nazemi MJ, et al. Thyroid autoimmunity and pemphigus vulgaris: is there a significant association? J Am Acad Dermatol. 2010;62:349–51. Daneshpazhooh M, Behjati J, Hashemi P, Shamohammadi S, Mortazavi H, Nazemi MJ, et al. Thyroid autoimmunity and pemphigus vulgaris: is there a significant association? J Am Acad Dermatol. 2010;62:349–51.
79.
Zurück zum Zitat Nisihara RM, de Bem RS, Hausberger R, Roxo VS, Pavoni DP, Petzl-Erler ML, et al. Prevalence of autoantibodies in patients with endemic pemphigus foliaceus (fogo selvagem). Arch Dermatol Res. 2003;295:133–7. Nisihara RM, de Bem RS, Hausberger R, Roxo VS, Pavoni DP, Petzl-Erler ML, et al. Prevalence of autoantibodies in patients with endemic pemphigus foliaceus (fogo selvagem). Arch Dermatol Res. 2003;295:133–7.
80.
Zurück zum Zitat Baldini E, Odorisio T, Sorrenti S, Catania A, Tartaglia F, Carbotta G, et al. Vitiligo and autoimmune thyroid disorders. Front Endocrinol (Lausanne). 2017;8:290. Baldini E, Odorisio T, Sorrenti S, Catania A, Tartaglia F, Carbotta G, et al. Vitiligo and autoimmune thyroid disorders. Front Endocrinol (Lausanne). 2017;8:290.
81.
Zurück zum Zitat Kim YC, Kim YJ, Kang HY, Sohn S, Lee ES. Histopathologic features in vitiligo. Am J Dermatopathol. 2008;30:112–6.CrossRefPubMed Kim YC, Kim YJ, Kang HY, Sohn S, Lee ES. Histopathologic features in vitiligo. Am J Dermatopathol. 2008;30:112–6.CrossRefPubMed
82.
Zurück zum Zitat Ferrari SM, Fallahi P, Santaguida G, Virili C, Ruffilli I, Ragusa F, et al. Circulating CXCL10 is increased in non-segmental vitiligo, in presence or absence of autoimmune thyroiditis. Autoimmun Rev. 2017;16:946–50. Ferrari SM, Fallahi P, Santaguida G, Virili C, Ruffilli I, Ragusa F, et al. Circulating CXCL10 is increased in non-segmental vitiligo, in presence or absence of autoimmune thyroiditis. Autoimmun Rev. 2017;16:946–50.
83.
Zurück zum Zitat Antonelli A, Ferrari SM, Fallahi P. The role of the Th1 chemokine CXCL10 in vitiligo. Ann Transl Med. 2015;3(Suppl 1):S16.PubMedPubMedCentral Antonelli A, Ferrari SM, Fallahi P. The role of the Th1 chemokine CXCL10 in vitiligo. Ann Transl Med. 2015;3(Suppl 1):S16.PubMedPubMedCentral
84.
Zurück zum Zitat Ezzedine K, Lim HW, Suzuki T, Katayama I, Hamzavi I, Lan CC, et al. Vitiligo global issue consensus conference panelists. Pigment Cell Melanoma Res. 2012;25:E1–13. Ezzedine K, Lim HW, Suzuki T, Katayama I, Hamzavi I, Lan CC, et al. Vitiligo global issue consensus conference panelists. Pigment Cell Melanoma Res. 2012;25:E1–13.
85.
Zurück zum Zitat Pandve HT. Vitiligo. is it just a dermatological disorder? Indian J Dermatol. 2008;53:40–1. Pandve HT. Vitiligo. is it just a dermatological disorder? Indian J Dermatol. 2008;53:40–1.
86.
Zurück zum Zitat Lai Y, Yew YW, Kennedy C, Schwartz RA. Vitiligo and depression: a systematic review and meta-analysis of observational studies. Br J Dermatol. 2016;177:708–18.CrossRef Lai Y, Yew YW, Kennedy C, Schwartz RA. Vitiligo and depression: a systematic review and meta-analysis of observational studies. Br J Dermatol. 2016;177:708–18.CrossRef
87.
Zurück zum Zitat Patel S, Rauf A, Khan H, Meher BR, ul Hassan SS. A holistic review on the autoimmune disease vitiligo with emphasis on the casual factors. Biomed Pharmacother. 2017;92:501–8.CrossRefPubMed Patel S, Rauf A, Khan H, Meher BR, ul Hassan SS. A holistic review on the autoimmune disease vitiligo with emphasis on the casual factors. Biomed Pharmacother. 2017;92:501–8.CrossRefPubMed
89.
90.
Zurück zum Zitat Rodrigues M, Ezzedine K, Hamzavi I, Pandya AG, Harris JE. Vitiligo Working Group. New discoveries in the pathogenesis and classification of vitiligo. J Am Acad Dermatol. 2017;77:1–13.CrossRefPubMed Rodrigues M, Ezzedine K, Hamzavi I, Pandya AG, Harris JE. Vitiligo Working Group. New discoveries in the pathogenesis and classification of vitiligo. J Am Acad Dermatol. 2017;77:1–13.CrossRefPubMed
91.
92.
Zurück zum Zitat Jin Y, Ferrara T, Gowan K, Holcomb C, Rastrou M, Erlich HA, et al. Next-generation DNA re-sequencing identifies common variants of TYR and HLA-A that modulate the risk of generalized vitiligo via antigen presentation. J Invest Dermatol. 2012;132:1730–3. Jin Y, Ferrara T, Gowan K, Holcomb C, Rastrou M, Erlich HA, et al. Next-generation DNA re-sequencing identifies common variants of TYR and HLA-A that modulate the risk of generalized vitiligo via antigen presentation. J Invest Dermatol. 2012;132:1730–3.
93.
Zurück zum Zitat Manolache L, Benea V. Stress in patients with alopecia areata and vitiligo. J Eur Acad Dermatol Venereol. 2007;21:921–8.CrossRefPubMed Manolache L, Benea V. Stress in patients with alopecia areata and vitiligo. J Eur Acad Dermatol Venereol. 2007;21:921–8.CrossRefPubMed
94.
Zurück zum Zitat Alkhateeb A, Fain PR, Thody A, Bennett DC, Spritz RA. Epidemiology of vitiligo and associated autoimmune diseases in Caucasian probands and their families. Pigement Cell Melanoma Res. 2003;16:208–14.CrossRef Alkhateeb A, Fain PR, Thody A, Bennett DC, Spritz RA. Epidemiology of vitiligo and associated autoimmune diseases in Caucasian probands and their families. Pigement Cell Melanoma Res. 2003;16:208–14.CrossRef
95.
Zurück zum Zitat Cunliffe WJ, Hall R, Newell DJ, Stevenson CJ. Vitiligo, thyroid disease and autoimmunity. Br J Dermatol. 1968;80:135–9.CrossRefPubMed Cunliffe WJ, Hall R, Newell DJ, Stevenson CJ. Vitiligo, thyroid disease and autoimmunity. Br J Dermatol. 1968;80:135–9.CrossRefPubMed
96.
Zurück zum Zitat Gill L, Zarbo A, Isedeh P, Jacobsen G, Lim HW, Hamzavi I. Comorbid autoimmune diseases in patients with vitiligo: a cross-sectional study. J Am Acad Dermatol. 2016;74:295–302.CrossRefPubMed Gill L, Zarbo A, Isedeh P, Jacobsen G, Lim HW, Hamzavi I. Comorbid autoimmune diseases in patients with vitiligo: a cross-sectional study. J Am Acad Dermatol. 2016;74:295–302.CrossRefPubMed
97.
Zurück zum Zitat Laberge G, Mailloux CM, Gowan K, Holland P, Bennett DC, Fain PR, et al. Early disease onset and increased risk of other autoimmune diseases in familial generalized vitiligo. Pigment Cell Res. 2005;18:300–5. Laberge G, Mailloux CM, Gowan K, Holland P, Bennett DC, Fain PR, et al. Early disease onset and increased risk of other autoimmune diseases in familial generalized vitiligo. Pigment Cell Res. 2005;18:300–5.
98.
Zurück zum Zitat Sheth VM, Guo Y, Qureshi AA. Comorbidities associated with vitiligo: a ten-year retrospective study. Dermatology. 2013;227:311–5.CrossRefPubMed Sheth VM, Guo Y, Qureshi AA. Comorbidities associated with vitiligo: a ten-year retrospective study. Dermatology. 2013;227:311–5.CrossRefPubMed
99.
Zurück zum Zitat Amerio P, Di Rollo D, Carbone A, Auriemma M, Marra ME, De Remigis P, et al. Polyglandular autoimmune diseases in a dermatological clinical setting: vitiligo-associated autoimmune diseases. Eur J Dermatol. 2010;20:354–8. Amerio P, Di Rollo D, Carbone A, Auriemma M, Marra ME, De Remigis P, et al. Polyglandular autoimmune diseases in a dermatological clinical setting: vitiligo-associated autoimmune diseases. Eur J Dermatol. 2010;20:354–8.
100.
Zurück zum Zitat Narita T, Oiso N, Fukai K, Kabashima K, Kawada A, Suzuki T. Generalized vitiligo and associated autoimmune diseases in Japanese patients and their families. Allergol Int. 2011;60:505–8.CrossRefPubMed Narita T, Oiso N, Fukai K, Kabashima K, Kawada A, Suzuki T. Generalized vitiligo and associated autoimmune diseases in Japanese patients and their families. Allergol Int. 2011;60:505–8.CrossRefPubMed
101.
Zurück zum Zitat Fallahi P, Ferrari SM, Ruffilli I, Elia G, Biricotti M, Vita R, et al. The association of other autoimmune diseases in patients with autoimmune thyroiditis: Review of the literature and report of a large series of patients. Autoimmun Rev. 2016;15:1125–8. Fallahi P, Ferrari SM, Ruffilli I, Elia G, Biricotti M, Vita R, et al. The association of other autoimmune diseases in patients with autoimmune thyroiditis: Review of the literature and report of a large series of patients. Autoimmun Rev. 2016;15:1125–8.
102.
Zurück zum Zitat Ruggeri RM, Trimarchi F, Giuffrida G, Certo R, Cama E, Campennì A, et al. Autoimmune comorbidities in Hashimoto's thyroiditis: different patterns of association in adulthood and childhood/adolescence. Eur J Endocrinol. 2017;176:133–41. Ruggeri RM, Trimarchi F, Giuffrida G, Certo R, Cama E, Campennì A, et al. Autoimmune comorbidities in Hashimoto's thyroiditis: different patterns of association in adulthood and childhood/adolescence. Eur J Endocrinol. 2017;176:133–41.
103.
Zurück zum Zitat Saylam Kurtipek G, Cihan FG, Erayman Demirbaş Ş, Ataseven A. The Frequency of autoimmune thyroid disease in alopecia areata and vitiligo patients. Biomed Res Int. 2015;2015:435947.CrossRefPubMedPubMedCentral Saylam Kurtipek G, Cihan FG, Erayman Demirbaş Ş, Ataseven A. The Frequency of autoimmune thyroid disease in alopecia areata and vitiligo patients. Biomed Res Int. 2015;2015:435947.CrossRefPubMedPubMedCentral
104.
Zurück zum Zitat Nejad SB, Qadim HH, Nazeman L, Fadaii R, Goldust M. Frequency of autoimmune diseases in those suffering from vitiligo in comparison with normal population. Pak J Biol Sci. 2013;16:570–4.CrossRefPubMed Nejad SB, Qadim HH, Nazeman L, Fadaii R, Goldust M. Frequency of autoimmune diseases in those suffering from vitiligo in comparison with normal population. Pak J Biol Sci. 2013;16:570–4.CrossRefPubMed
105.
Zurück zum Zitat Colucci R, Lotti F, Dragoni F, Arunachalam M, Lotti T, Benvenga S, et al. High prevalence of circulating autoantibodies against thyroid hormones in vitiligo and correlation with clinical and historical parameters of patients. Br J Dermatol. 2014;171:786–98. Colucci R, Lotti F, Dragoni F, Arunachalam M, Lotti T, Benvenga S, et al. High prevalence of circulating autoantibodies against thyroid hormones in vitiligo and correlation with clinical and historical parameters of patients. Br J Dermatol. 2014;171:786–98.
106.
Zurück zum Zitat Lazzeri L, Colucci R, Cammi A, Dragoni F, Moretti S. Adult onset vitiligo: multivariate analysis suggests the need for a thyroid screening. Biomed Res Int. 2016;2016:8065765.CrossRefPubMedPubMedCentral Lazzeri L, Colucci R, Cammi A, Dragoni F, Moretti S. Adult onset vitiligo: multivariate analysis suggests the need for a thyroid screening. Biomed Res Int. 2016;2016:8065765.CrossRefPubMedPubMedCentral
107.
Zurück zum Zitat Bae JM, Lee JH, Yun JS, Han B, Han TY. Vitiligo and overt thyroid diseases: A nationwide population-based study in Korea. J Am Acad Dermatol. 2017;76:871–8.CrossRefPubMed Bae JM, Lee JH, Yun JS, Han B, Han TY. Vitiligo and overt thyroid diseases: A nationwide population-based study in Korea. J Am Acad Dermatol. 2017;76:871–8.CrossRefPubMed
108.
109.
Zurück zum Zitat Vrijman C, Kroon MW, Limpens J, Leeflang MM, Luiten RM, van der Veen JP, et al. The prevalence of thyroid disease in patients with vitiligo: a systematic review. Br J Dermatol. 2012;167:1224–35. Vrijman C, Kroon MW, Limpens J, Leeflang MM, Luiten RM, van der Veen JP, et al. The prevalence of thyroid disease in patients with vitiligo: a systematic review. Br J Dermatol. 2012;167:1224–35.
110.
Zurück zum Zitat Colucci R, Lotti F, Arunachalam M, Lotti T, Dragoni F, Benvenga S, et al. Correlation of serum thyroid hormones autoantibodies with self-reported exposure to thyroid disruptors in a group of nonsegmental vitiligo patients. Arch Environ Contam Toxicol. 2015;69:181–90. Colucci R, Lotti F, Arunachalam M, Lotti T, Dragoni F, Benvenga S, et al. Correlation of serum thyroid hormones autoantibodies with self-reported exposure to thyroid disruptors in a group of nonsegmental vitiligo patients. Arch Environ Contam Toxicol. 2015;69:181–90.
111.
Zurück zum Zitat Shong YK, Kim JA. Vitiligo in autoimmune thyroid disease. Thyroidology. 1991;3:89–91.PubMed Shong YK, Kim JA. Vitiligo in autoimmune thyroid disease. Thyroidology. 1991;3:89–91.PubMed
112.
Zurück zum Zitat Artantaş S, Gül U, Kiliç A, Güler S. Skin findings in thyroid diseases. Eur J Intern Med. 2009;20:158–61.CrossRefPubMed Artantaş S, Gül U, Kiliç A, Güler S. Skin findings in thyroid diseases. Eur J Intern Med. 2009;20:158–61.CrossRefPubMed
113.
Zurück zum Zitat Vita R, Santaguida MG, Virili C, Segni M, Galletti M, Mandolfino M, et al. Serum thyroid hormone antibodies are frequent in patients with polyglandular autoimmune syndrome type 3, particularly in those who require thyroxine treatment. Front Endocrinol. 2017;8:212. Vita R, Santaguida MG, Virili C, Segni M, Galletti M, Mandolfino M, et al. Serum thyroid hormone antibodies are frequent in patients with polyglandular autoimmune syndrome type 3, particularly in those who require thyroxine treatment. Front Endocrinol. 2017;8:212.
114.
115.
Zurück zum Zitat Powell RJ, Du Toit GL, Siddique N, Leech SC, Dixon TA, Clark AT, et al. British Society for Allergy and Clinical Immunology (BSACI). BSACI guidelines for the management of chronic urticaria and angio-oedema. Clin Exp Allergy. 2007;37(5):631–50. Powell RJ, Du Toit GL, Siddique N, Leech SC, Dixon TA, Clark AT, et al. British Society for Allergy and Clinical Immunology (BSACI). BSACI guidelines for the management of chronic urticaria and angio-oedema. Clin Exp Allergy. 2007;37(5):631–50.
116.
Zurück zum Zitat Konstantinou GN, Asero R, Maurer M, Sabroe RA, Schmid-Grendelmeier P, Grattan CE. EAACI/GA(2)LEN task force consensus report: the autologous serum skin test in urticaria. Allergy. 2009;64:1256–68.CrossRefPubMed Konstantinou GN, Asero R, Maurer M, Sabroe RA, Schmid-Grendelmeier P, Grattan CE. EAACI/GA(2)LEN task force consensus report: the autologous serum skin test in urticaria. Allergy. 2009;64:1256–68.CrossRefPubMed
117.
Zurück zum Zitat Tedeschi A, Cottini M, Asero R. Simultaneous occurrence of chronic autoimmune urticaria and non-allergic asthma: a common mechanism? Eur Ann Allergy Clin Immunol. 2009;41:56–9.PubMed Tedeschi A, Cottini M, Asero R. Simultaneous occurrence of chronic autoimmune urticaria and non-allergic asthma: a common mechanism? Eur Ann Allergy Clin Immunol. 2009;41:56–9.PubMed
118.
Zurück zum Zitat Confino-Cohen R, Chodick G, Shalev V, Leshno M, Kimhi O, Goldberg A. Chronic urticaria and autoimmunity: associations found in a large population study. J Allergy Clin Immunol. 2012;129:1307–13.CrossRefPubMed Confino-Cohen R, Chodick G, Shalev V, Leshno M, Kimhi O, Goldberg A. Chronic urticaria and autoimmunity: associations found in a large population study. J Allergy Clin Immunol. 2012;129:1307–13.CrossRefPubMed
119.
Zurück zum Zitat Criado PR, Criado RF, Maruta CW, Reis VM. Chronic urticaria in adults: state-of-the-art in the new millennium. An Bras Dermatol. 2015;90:74–89.CrossRefPubMedPubMedCentral Criado PR, Criado RF, Maruta CW, Reis VM. Chronic urticaria in adults: state-of-the-art in the new millennium. An Bras Dermatol. 2015;90:74–89.CrossRefPubMedPubMedCentral
120.
Zurück zum Zitat Kolkhir P, Borzova E, Grattan C, Asero R, Pogorelov D, Maurer M. Autoimmune comorbidity in chronic spontaneous urticaria: A systematic review. Autoimmun Rev. 2017;16:1196–208.CrossRefPubMed Kolkhir P, Borzova E, Grattan C, Asero R, Pogorelov D, Maurer M. Autoimmune comorbidity in chronic spontaneous urticaria: A systematic review. Autoimmun Rev. 2017;16:1196–208.CrossRefPubMed
121.
Zurück zum Zitat Rottem M. Chronic urticaria and autoimmune thyroid disease: is there a link? Autoimmun Rev. 2003;2:69–72.CrossRefPubMed Rottem M. Chronic urticaria and autoimmune thyroid disease: is there a link? Autoimmun Rev. 2003;2:69–72.CrossRefPubMed
122.
Zurück zum Zitat Bagnasco M, Minciullo PL, Saraceno GS, Gangemi S, Benvenga S. Urticaria and thyroid autoimmunity. Thyroid. 2011;21:401–10.CrossRefPubMed Bagnasco M, Minciullo PL, Saraceno GS, Gangemi S, Benvenga S. Urticaria and thyroid autoimmunity. Thyroid. 2011;21:401–10.CrossRefPubMed
123.
Zurück zum Zitat Dreskin SC, Andrews KY. The thyroid and urticaria. Curr Opin Allergy Clin Immunol. 2005;5:408–12.CrossRefPubMed Dreskin SC, Andrews KY. The thyroid and urticaria. Curr Opin Allergy Clin Immunol. 2005;5:408–12.CrossRefPubMed
124.
Zurück zum Zitat Kolkhir P, Metz M, AltricHashimoto thyroiditiser S, Maurer M. Comorbidity of chronic spontaneous urticaria and autoimmune thyroid diseases: A systematic review. Allergy. 2017;72:1440–60.CrossRefPubMed Kolkhir P, Metz M, AltricHashimoto thyroiditiser S, Maurer M. Comorbidity of chronic spontaneous urticaria and autoimmune thyroid diseases: A systematic review. Allergy. 2017;72:1440–60.CrossRefPubMed
125.
Zurück zum Zitat O'Donnell BF, Francis DM, Swana GT, Seed PT, Kobza Black A, Greaves MW. Thyroid autoimmunity in chronic urticaria. Br J Dermatol. 2005;153:331–5.CrossRefPubMed O'Donnell BF, Francis DM, Swana GT, Seed PT, Kobza Black A, Greaves MW. Thyroid autoimmunity in chronic urticaria. Br J Dermatol. 2005;153:331–5.CrossRefPubMed
126.
Zurück zum Zitat Ruggeri RM, Imbesi S, Saitta S, Campennì A, Cannavò S, Trimarchi F, et al. Chronic idiopathic urticaria and Graves' disease. J Endocrinol Invest. 2013;36:531–6. Ruggeri RM, Imbesi S, Saitta S, Campennì A, Cannavò S, Trimarchi F, et al. Chronic idiopathic urticaria and Graves' disease. J Endocrinol Invest. 2013;36:531–6.
127.
Zurück zum Zitat Lanigan SW, Short P, Moult P. The association of chronic urticaria and thyroid autoimmunity. Clin Exp Dermatol. 1987;12:335–8.CrossRefPubMed Lanigan SW, Short P, Moult P. The association of chronic urticaria and thyroid autoimmunity. Clin Exp Dermatol. 1987;12:335–8.CrossRefPubMed
128.
Zurück zum Zitat Hordinsky MK. Overview of alopecia areata. J Invest Dermatol. 2013;16:S13–5.CrossRef Hordinsky MK. Overview of alopecia areata. J Invest Dermatol. 2013;16:S13–5.CrossRef
129.
Zurück zum Zitat Spano F, Donovan JC. Alopecia areata. Part 1:pathogenesis, diagnosis, and prognosis. Can Fam Physician. 2015;61:751–5.PubMedPubMedCentral Spano F, Donovan JC. Alopecia areata. Part 1:pathogenesis, diagnosis, and prognosis. Can Fam Physician. 2015;61:751–5.PubMedPubMedCentral
130.
Zurück zum Zitat Bodemer C, Peuchmaur M, Fraitaig S, Chatenoud L, Brousse N, De Prost Y. Role of cytotoxic T cells in chronic alopecia areata. J Invest Dermatol. 2000;114:112–6.CrossRefPubMed Bodemer C, Peuchmaur M, Fraitaig S, Chatenoud L, Brousse N, De Prost Y. Role of cytotoxic T cells in chronic alopecia areata. J Invest Dermatol. 2000;114:112–6.CrossRefPubMed
131.
132.
Zurück zum Zitat Bertolini M, Zilio F, Rossi A, Kleditzsch P, Emelianov VE, Gilhar A, et al. Abnormal interactions between perifollicular mast cells and CD8+ T-cells may contribute to the pathogenesis of alopecia areata. PLoS One. 2014;9:e94260. Bertolini M, Zilio F, Rossi A, Kleditzsch P, Emelianov VE, Gilhar A, et al. Abnormal interactions between perifollicular mast cells and CD8+ T-cells may contribute to the pathogenesis of alopecia areata. PLoS One. 2014;9:e94260.
133.
Zurück zum Zitat Wang EH, Yu M, Breitkopf T, Akhoundsadegh N, Wang X, Shi FT, et al. Identification of autoantigen epitopes in alopecia areata. J Invest Dermatol. 2016;136:1617–26.CrossRefPubMed Wang EH, Yu M, Breitkopf T, Akhoundsadegh N, Wang X, Shi FT, et al. Identification of autoantigen epitopes in alopecia areata. J Invest Dermatol. 2016;136:1617–26.CrossRefPubMed
134.
Zurück zum Zitat Bertolini M, Rossi A, Paus R. Cover Image: Are melanocyte-associated peptides the elusive autoantigens in alopecia areata? Br J Dermatol. 2017;176:1106.CrossRefPubMed Bertolini M, Rossi A, Paus R. Cover Image: Are melanocyte-associated peptides the elusive autoantigens in alopecia areata? Br J Dermatol. 2017;176:1106.CrossRefPubMed
135.
Zurück zum Zitat Islam N, Leung PS, Huntley AC, Gershwin ME. The autoimmune basis of alopecia areata: a comprehensive review. Autoimmun Rev. 2015 Feb;14(2):81–9.CrossRefPubMed Islam N, Leung PS, Huntley AC, Gershwin ME. The autoimmune basis of alopecia areata: a comprehensive review. Autoimmun Rev. 2015 Feb;14(2):81–9.CrossRefPubMed
137.
Zurück zum Zitat Patel D, Li P, Bauer AJ, Castelo-Soccio C. Screening guidelines for thyroid function in children with alopecia areata. JAMA Dermatol. 2017;153:1307–10.CrossRefPubMedPubMedCentral Patel D, Li P, Bauer AJ, Castelo-Soccio C. Screening guidelines for thyroid function in children with alopecia areata. JAMA Dermatol. 2017;153:1307–10.CrossRefPubMedPubMedCentral
138.
Zurück zum Zitat Huang KP, Mullangi S, Guo Y, Qureshi AA. Autoimmune, atopic, and mental health comorbidity conditions associated with alopecia areata in the United Stayes. JAMA Dermatol. 2013;149:789–94.CrossRefPubMed Huang KP, Mullangi S, Guo Y, Qureshi AA. Autoimmune, atopic, and mental health comorbidity conditions associated with alopecia areata in the United Stayes. JAMA Dermatol. 2013;149:789–94.CrossRefPubMed
139.
Zurück zum Zitat Baars MP, Greebe RJ, Pop VJM. High prevalence of thyroid peroxidase antibodies in patients with alopecia areata. J Eur Acad Dermatol Venereol. 2013;27:e136-47.CrossRef Baars MP, Greebe RJ, Pop VJM. High prevalence of thyroid peroxidase antibodies in patients with alopecia areata. J Eur Acad Dermatol Venereol. 2013;27:e136-47.CrossRef
140.
Zurück zum Zitat Conic RZ, Miller R, Piliang M, Bergfeld W, Mesinkovska NA. Comorbidities in patients with alopecia areata. J Am Acad Dermatol. 2017;76:755–7.CrossRefPubMed Conic RZ, Miller R, Piliang M, Bergfeld W, Mesinkovska NA. Comorbidities in patients with alopecia areata. J Am Acad Dermatol. 2017;76:755–7.CrossRefPubMed
141.
Zurück zum Zitat Bin Saif GA. Severe subtype of alopecia areata is highly associated with thyroid autoimmunity. Saudi Med J. 2016;37:656–61.CrossRefPubMed Bin Saif GA. Severe subtype of alopecia areata is highly associated with thyroid autoimmunity. Saudi Med J. 2016;37:656–61.CrossRefPubMed
143.
Zurück zum Zitat Guran T, Bircan R, Turan S, Bereket A. Alopecia: association with resistance to thyroid hormone. J Pediatr Endocrinol Metab. 2009;22:1075–81.PubMed Guran T, Bircan R, Turan S, Bereket A. Alopecia: association with resistance to thyroid hormone. J Pediatr Endocrinol Metab. 2009;22:1075–81.PubMed
144.
Zurück zum Zitat Maatough A, Whitfield GK, Brook L, Hsieh D, Palade P, Hsieh JC. Human Hairless Protein Roles in Skin/Hair and Emerging Connections to Brain and Other Cancers. J Cell Biochem. 2018;119:69–80.CrossRefPubMed Maatough A, Whitfield GK, Brook L, Hsieh D, Palade P, Hsieh JC. Human Hairless Protein Roles in Skin/Hair and Emerging Connections to Brain and Other Cancers. J Cell Biochem. 2018;119:69–80.CrossRefPubMed
145.
Zurück zum Zitat Parisi R, Symmons DP, Griffiths CE, Ashcroft DM. Identification and Management of Psoriasis and Associated ComorbidiTy (IMPACT) project team. Global epidemiology of psoriasis: a systematic review of incidence and prevalence. J Invest Dermatol. 2013;133:377–85.CrossRefPubMed Parisi R, Symmons DP, Griffiths CE, Ashcroft DM. Identification and Management of Psoriasis and Associated ComorbidiTy (IMPACT) project team. Global epidemiology of psoriasis: a systematic review of incidence and prevalence. J Invest Dermatol. 2013;133:377–85.CrossRefPubMed
146.
Zurück zum Zitat Karczewski J, Dobrowolska A, Rychlewska-Hańczewska A, Adamski Z. New insights into the role of T cells in pathogenesis of psoriasis and psoriatic arthritis. Autoimmunity. 2016;49:435–50.CrossRefPubMed Karczewski J, Dobrowolska A, Rychlewska-Hańczewska A, Adamski Z. New insights into the role of T cells in pathogenesis of psoriasis and psoriatic arthritis. Autoimmunity. 2016;49:435–50.CrossRefPubMed
147.
Zurück zum Zitat Alwan W, Nestle FO. Pathogenesis and treatment of psoriasis: exploiting pathophysiological pathways for precision medicine. Clin Exp Rheumatol. 2015;33(5 Suppl 93):S2–6.PubMed Alwan W, Nestle FO. Pathogenesis and treatment of psoriasis: exploiting pathophysiological pathways for precision medicine. Clin Exp Rheumatol. 2015;33(5 Suppl 93):S2–6.PubMed
148.
Zurück zum Zitat Farber EM, Nall ML. The natural history of psoriasis in 5,600 patients. Dermatologica. 1974;148:1–18.CrossRefPubMed Farber EM, Nall ML. The natural history of psoriasis in 5,600 patients. Dermatologica. 1974;148:1–18.CrossRefPubMed
149.
Zurück zum Zitat Schmitt-Egenolf M, Eiermann TH, Boehncke WH, Ständer M, Sterry W. Familial juvenile onset psoriasis is associated with the human leukocyte antigen (HLA) class I side of the extended haplotype Cw6-B57-DRB1*0701-DQA1*0201-DQB1*0303: a population- and family-based study. J Invest Dermatol. 1996;106:711–4.CrossRefPubMed Schmitt-Egenolf M, Eiermann TH, Boehncke WH, Ständer M, Sterry W. Familial juvenile onset psoriasis is associated with the human leukocyte antigen (HLA) class I side of the extended haplotype Cw6-B57-DRB1*0701-DQA1*0201-DQB1*0303: a population- and family-based study. J Invest Dermatol. 1996;106:711–4.CrossRefPubMed
151.
Zurück zum Zitat Tsoi LC, Spain SL, Ellinghaus E, Stuart PE, Capon F, Knig J, et al. Enhanced meta-analysis and replication studies identify five new psoriasis susceptibility loci. Nat Commun. 2015;6:7001. Tsoi LC, Spain SL, Ellinghaus E, Stuart PE, Capon F, Knig J, et al. Enhanced meta-analysis and replication studies identify five new psoriasis susceptibility loci. Nat Commun. 2015;6:7001.
152.
Zurück zum Zitat Yin X, Low HQ, Wang L, Li Y, Ellinghaus E, Han J, et al. Genome-wide meta-analysis identifies multiple novel associations and ethnic heterogeneity of psoriasis susceptibility. Nat Commun. 2015;6:6916. Yin X, Low HQ, Wang L, Li Y, Ellinghaus E, Han J, et al. Genome-wide meta-analysis identifies multiple novel associations and ethnic heterogeneity of psoriasis susceptibility. Nat Commun. 2015;6:6916.
153.
Zurück zum Zitat Khan SR, Bano A, Wakkee M, Korevaar TIM, Franco OH, Nijsten TEC, et al. The association of autoimmune thyroid disease (AITD) with psoriatic disease: a prospective cohort study, systematic review and meta-analysis. Eur J Endocrinol. 2017;177:347–59. Khan SR, Bano A, Wakkee M, Korevaar TIM, Franco OH, Nijsten TEC, et al. The association of autoimmune thyroid disease (AITD) with psoriatic disease: a prospective cohort study, systematic review and meta-analysis. Eur J Endocrinol. 2017;177:347–59.
154.
Zurück zum Zitat Wu JJ, Nguyen TU, Poon KY, Herrinton LJ. The association of psoriasis with autoimmune diseases. J Am Acad Dermatol. 2012;67:924–30.CrossRefPubMed Wu JJ, Nguyen TU, Poon KY, Herrinton LJ. The association of psoriasis with autoimmune diseases. J Am Acad Dermatol. 2012;67:924–30.CrossRefPubMed
155.
Zurück zum Zitat Antonelli A, Delle Sedie A, Fallahi P, Ferrari SM, Maccheroni M, Ferrannini E, et al. High prevalence of thyroid autoimmunity and hypothyroidism in patients with psoriatic arthritis. J Rheumatol. 2006;33:2026–8. Antonelli A, Delle Sedie A, Fallahi P, Ferrari SM, Maccheroni M, Ferrannini E, et al. High prevalence of thyroid autoimmunity and hypothyroidism in patients with psoriatic arthritis. J Rheumatol. 2006;33:2026–8.
156.
Zurück zum Zitat Peluso R, Lupoli GA, Del Puente A, Iervolino S, Bruner V, Lupoli R, et al. Prevalence of thyroid autoimmunity in patients with spondyloarthropathies. J Rheumatol. 2011;38:1371–7. Peluso R, Lupoli GA, Del Puente A, Iervolino S, Bruner V, Lupoli R, et al. Prevalence of thyroid autoimmunity in patients with spondyloarthropathies. J Rheumatol. 2011;38:1371–7.
157.
Zurück zum Zitat Tsai TF, Wang TS, Hung ST, Tsai PI, Schenkel B, Zhang M, et al. Epidemiology and comorbidities of psoriasis patients in a national database in Taiwan. J Dermatol Sci. 2011;63:40–6. Tsai TF, Wang TS, Hung ST, Tsai PI, Schenkel B, Zhang M, et al. Epidemiology and comorbidities of psoriasis patients in a national database in Taiwan. J Dermatol Sci. 2011;63:40–6.
158.
Zurück zum Zitat Arakawa A, Siewert K, Stöhr J, Besgen P, Kim SM, Rühl G, et al. Melanocyte antigen triggers autoimmunity in human psoriasis. J Exp Med. 2015;212:2203–12. Arakawa A, Siewert K, Stöhr J, Besgen P, Kim SM, Rühl G, et al. Melanocyte antigen triggers autoimmunity in human psoriasis. J Exp Med. 2015;212:2203–12.
159.
160.
161.
Zurück zum Zitat Simmonds MJ. GWAS in autoimmune thyroid disease: redefining our understanding of pathogenesis. Nat Rev Endocrinol. 2013;9:277–87.CrossRefPubMed Simmonds MJ. GWAS in autoimmune thyroid disease: redefining our understanding of pathogenesis. Nat Rev Endocrinol. 2013;9:277–87.CrossRefPubMed
162.
Zurück zum Zitat Jin Y, Birlea SA, Fain PR, Ferrara TM, Ben S, Riccardi SL, et al. Genome-wide association analyses identify 13 new susceptibility loci for generalized vitiligo. Nat Genet. 2012;44:676–80. Jin Y, Birlea SA, Fain PR, Ferrara TM, Ben S, Riccardi SL, et al. Genome-wide association analyses identify 13 new susceptibility loci for generalized vitiligo. Nat Genet. 2012;44:676–80.
163.
Zurück zum Zitat Medici M, Porcu E, Pistis G, Teumer A, Brown SJ, Jensen RA, et al. Identification of novel genetic Loci associated with thyroid peroxidase antibodies and clinical thyroid disease. PLoS Genet. 2014;10:e1004123. Medici M, Porcu E, Pistis G, Teumer A, Brown SJ, Jensen RA, et al. Identification of novel genetic Loci associated with thyroid peroxidase antibodies and clinical thyroid disease. PLoS Genet. 2014;10:e1004123.
164.
Zurück zum Zitat Alkhateeb A, Jarun Y, TasHashimoto thyroiditisoush R. Polymorphisms in NLRP1 gene and susceptibility to autoimmune thyroid disease. Autoimmunity. 2013;46:215–21.CrossRefPubMed Alkhateeb A, Jarun Y, TasHashimoto thyroiditisoush R. Polymorphisms in NLRP1 gene and susceptibility to autoimmune thyroid disease. Autoimmunity. 2013;46:215–21.CrossRefPubMed
165.
Zurück zum Zitat Alkhateeb A, Stetler GL, Old W, Talbert J, Uhlhorn C, Taylor M, et al. Mapping of an autoimmunity susceptibility locus (AIS1) to chromosome 1p31.3-p32.2. Hum Mol Genet. 2002;11:661–7. Alkhateeb A, Stetler GL, Old W, Talbert J, Uhlhorn C, Taylor M, et al. Mapping of an autoimmunity susceptibility locus (AIS1) to chromosome 1p31.3-p32.2. Hum Mol Genet. 2002;11:661–7.
166.
Zurück zum Zitat Fain PR, Gowan K, LaBerge GS, Alkhateeb A, Stetler GL, Talbert J, et al. A genome wide screen for generalized vitiligo: confirmation of AIS1 on chromosome 1p31 and evidence for additional susceptibility loci. Am J Hum Genet. 2003;72:1560–4. Fain PR, Gowan K, LaBerge GS, Alkhateeb A, Stetler GL, Talbert J, et al. A genome wide screen for generalized vitiligo: confirmation of AIS1 on chromosome 1p31 and evidence for additional susceptibility loci. Am J Hum Genet. 2003;72:1560–4.
167.
Zurück zum Zitat Spritz RA, Gowan K, Bennett DC, Fain PR. Novel vitiligo susceptibility loci on chromosomes 7 (AIS2) and 8 (AIS3), confirmation of SLEV1 on chromosome 17, and their roles in an autoimmune diathesis. Am J Hum Genet. 2004;74:188–91.CrossRefPubMedPubMedCentral Spritz RA, Gowan K, Bennett DC, Fain PR. Novel vitiligo susceptibility loci on chromosomes 7 (AIS2) and 8 (AIS3), confirmation of SLEV1 on chromosome 17, and their roles in an autoimmune diathesis. Am J Hum Genet. 2004;74:188–91.CrossRefPubMedPubMedCentral
168.
Zurück zum Zitat Schunter JA, Löffler D, Wiesner T, Kovacs P, Badenhoop K, Aust G, et al. Körner A. A novel FoxD3 variant is associated with vitiligo and elevated thyroid auto-antibodies. J Clin Endocrinol Metab. 2015;100:E1335–42. Schunter JA, Löffler D, Wiesner T, Kovacs P, Badenhoop K, Aust G, et al. Körner A. A novel FoxD3 variant is associated with vitiligo and elevated thyroid auto-antibodies. J Clin Endocrinol Metab. 2015;100:E1335–42.
169.
Zurück zum Zitat Gong Q, Li X, Gong Q, Zhu W, Song G, Lu Y. Hashimoto’s thyroiditis could be secondary to vitiligo: the possibility of antigen crossover and oxidative stress between the two diseases. Arch Dermatol Res. 2016;308:277–81.CrossRefPubMed Gong Q, Li X, Gong Q, Zhu W, Song G, Lu Y. Hashimoto’s thyroiditis could be secondary to vitiligo: the possibility of antigen crossover and oxidative stress between the two diseases. Arch Dermatol Res. 2016;308:277–81.CrossRefPubMed
170.
Zurück zum Zitat Slominski A, Wortsman J, Kohn L, Ain KB, Venkataraman GM, Pisarchik A, et al. Expression of hypothalamic-pituitary-thyroid axis related genes in the human skin. J Invest Dermatol. 2002;119:1449–55. Slominski A, Wortsman J, Kohn L, Ain KB, Venkataraman GM, Pisarchik A, et al. Expression of hypothalamic-pituitary-thyroid axis related genes in the human skin. J Invest Dermatol. 2002;119:1449–55.
171.
Zurück zum Zitat Cianfarani F, Baldini E, Cavalli A, Marchioni E, Lembo L, Teson M, et al. TSH receptor and thyroid-specific gene expression in human skin. J Invest Dermatol. 2010;130:93–101. Cianfarani F, Baldini E, Cavalli A, Marchioni E, Lembo L, Teson M, et al. TSH receptor and thyroid-specific gene expression in human skin. J Invest Dermatol. 2010;130:93–101.
172.
Zurück zum Zitat Ellerhorst JA, Sendi-Naderi A, Johnson MK, Cooke CP, Dang SM, Diwan AH. Human melanoma cells express functional receptors for thyroid-stimulating hormone. Endocr Relat Cancer. 2006;13:1269–77.CrossRefPubMed Ellerhorst JA, Sendi-Naderi A, Johnson MK, Cooke CP, Dang SM, Diwan AH. Human melanoma cells express functional receptors for thyroid-stimulating hormone. Endocr Relat Cancer. 2006;13:1269–77.CrossRefPubMed
173.
Zurück zum Zitat Pattwell Dm LKJ, Watson RE, Paus R. HaCaT keratinocytes express functionalreceptors for thyroid-stimulating hormone. J Dermatol Sci. 2010;59:52–5.CrossRefPubMed Pattwell Dm LKJ, Watson RE, Paus R. HaCaT keratinocytes express functionalreceptors for thyroid-stimulating hormone. J Dermatol Sci. 2010;59:52–5.CrossRefPubMed
174.
Zurück zum Zitat Bodó E, Kany B, Gáspár E, Knüver J, Kromminga A, Ramot Y, et al. Thyroid-stimulating hormone, a novel, locally produced modulator of human epidermal functions, is regulated by thyrotropin-releasing hormone and thyroid hormones. Endocrinology. 2010;151:1633–42. Bodó E, Kany B, Gáspár E, Knüver J, Kromminga A, Ramot Y, et al. Thyroid-stimulating hormone, a novel, locally produced modulator of human epidermal functions, is regulated by thyrotropin-releasing hormone and thyroid hormones. Endocrinology. 2010;151:1633–42.
175.
Zurück zum Zitat Vidali S, Knuever J, Lerchner J, Giesen M, Bíró T, Klinger M, et al. Hypothalamic-pituitary-thyroid axis hormones stimulate mitochondrial function and biogenesis in human hair follicles. J Invest Dermatol. 2014;134:33–42. Vidali S, Knuever J, Lerchner J, Giesen M, Bíró T, Klinger M, et al. Hypothalamic-pituitary-thyroid axis hormones stimulate mitochondrial function and biogenesis in human hair follicles. J Invest Dermatol. 2014;134:33–42.
176.
Zurück zum Zitat Bodó E, Kromminga A, Bíró T, Borbíró I, Gáspár E, Zmijewski MA, et al. Human female hair follicles are a direct, nonclassical target for thyroid-stimulating hormone. J Invest Dermatol. 2009;129:1126–39. Bodó E, Kromminga A, Bíró T, Borbíró I, Gáspár E, Zmijewski MA, et al. Human female hair follicles are a direct, nonclassical target for thyroid-stimulating hormone. J Invest Dermatol. 2009;129:1126–39.
177.
Zurück zum Zitat Silvares MR, Fortes MR, Nascimento RA, Padovani CR, Miot HA, Nogueira CR, et al. Thyrotropin receptor gene expression in the association between chronic spontaneous urticaria and Hashimoto's thyroiditis. Int J Dermatol. 2017;56:547–52. Silvares MR, Fortes MR, Nascimento RA, Padovani CR, Miot HA, Nogueira CR, et al. Thyrotropin receptor gene expression in the association between chronic spontaneous urticaria and Hashimoto's thyroiditis. Int J Dermatol. 2017;56:547–52.
178.
Zurück zum Zitat AltricHashimoto thyroiditiser S, Peter HJ, Pisarevskaja D, Metz M, Martus P, Maurer M. IgE mediated autoallergy against thyroid peroxidase--a novel pathomechanism of chronic spontaneous urticaria? PLoS One. 2011;6:e14794.CrossRef AltricHashimoto thyroiditiser S, Peter HJ, Pisarevskaja D, Metz M, Martus P, Maurer M. IgE mediated autoallergy against thyroid peroxidase--a novel pathomechanism of chronic spontaneous urticaria? PLoS One. 2011;6:e14794.CrossRef
179.
180.
Zurück zum Zitat Burman KD, Mckinley-Grant L. Dermatologic aspects of thyroid disease. Clin Dermatol. 2006;24:247–55.CrossRefPubMed Burman KD, Mckinley-Grant L. Dermatologic aspects of thyroid disease. Clin Dermatol. 2006;24:247–55.CrossRefPubMed
181.
Zurück zum Zitat Hanley K, Rassner U, Elias PM, Williams ML, Feingold KR. Epidermal barrier ontogenesis: maturation in serum-free media and acceleration by glucocorticoid and thyroid hormone but not selected growth factors. J Invest Dermatol. 1996;106:404–11.CrossRefPubMed Hanley K, Rassner U, Elias PM, Williams ML, Feingold KR. Epidermal barrier ontogenesis: maturation in serum-free media and acceleration by glucocorticoid and thyroid hormone but not selected growth factors. J Invest Dermatol. 1996;106:404–11.CrossRefPubMed
182.
Zurück zum Zitat Tomić-Canić M, Day D, Samuels HH, Freedberg IM, Blumenberg M. Novel regulation of keratin gene expression by thyroid hormone and retinoid receptor. J Biol Chem. 1996;271:1416–23.CrossRefPubMed Tomić-Canić M, Day D, Samuels HH, Freedberg IM, Blumenberg M. Novel regulation of keratin gene expression by thyroid hormone and retinoid receptor. J Biol Chem. 1996;271:1416–23.CrossRefPubMed
183.
Zurück zum Zitat Kömüves LG, Hanley K, Jiang Y, Elias PM, Williams ML, Feingold KR. Ligands and activators of nuclear hormone receptors regulate epidermal differentiation during fetal rat skin development. J Invest Dermatol. 1998;111:429–33.CrossRefPubMed Kömüves LG, Hanley K, Jiang Y, Elias PM, Williams ML, Feingold KR. Ligands and activators of nuclear hormone receptors regulate epidermal differentiation during fetal rat skin development. J Invest Dermatol. 1998;111:429–33.CrossRefPubMed
184.
Zurück zum Zitat Slominski A, Wortsman J. Neuroendocrinology of the skin. Endocr Rev. 2000;21:457–87.PubMed Slominski A, Wortsman J. Neuroendocrinology of the skin. Endocr Rev. 2000;21:457–87.PubMed
185.
Zurück zum Zitat Safer JD, Crawford TM, Holick MF. A role for thyroid hormone in wound healing through keratin gene expression. Endocrinology. 2004;145:2357–61.CrossRefPubMed Safer JD, Crawford TM, Holick MF. A role for thyroid hormone in wound healing through keratin gene expression. Endocrinology. 2004;145:2357–61.CrossRefPubMed
186.
Zurück zum Zitat Radoja N, Stojadinovic O, Waseem A, Tomic-Canic M, Milisavljevic V, Teebor S, et al. Thyroid hormone and gamma interferon specifically increase K15 keratin gene transcription. Mol Cell Biol. 2004;24:3168–79. Radoja N, Stojadinovic O, Waseem A, Tomic-Canic M, Milisavljevic V, Teebor S, et al. Thyroid hormone and gamma interferon specifically increase K15 keratin gene transcription. Mol Cell Biol. 2004;24:3168–79.
187.
Zurück zum Zitat Refetoff S, Matalon R, Bigazzi M. Metabolism of L-thyroxine (T4) and L-triiodothyronine (T3) by human fibroblasts in tissue culture: evidence for cellular binding proteins and conversion of T4 to T3. Endocrinology. 1972;91:934–47.CrossRefPubMed Refetoff S, Matalon R, Bigazzi M. Metabolism of L-thyroxine (T4) and L-triiodothyronine (T3) by human fibroblasts in tissue culture: evidence for cellular binding proteins and conversion of T4 to T3. Endocrinology. 1972;91:934–47.CrossRefPubMed
188.
Zurück zum Zitat Huang TS, Chopra IJ, Beredo A, Solomon DH, Chua Teco GN. Skin is an active site for the inner ring monodeiodination of thyroxine to 3,3’,5’-triiodiothyronine. Endocrinology. 1985;17:2106–13.CrossRef Huang TS, Chopra IJ, Beredo A, Solomon DH, Chua Teco GN. Skin is an active site for the inner ring monodeiodination of thyroxine to 3,3’,5’-triiodiothyronine. Endocrinology. 1985;17:2106–13.CrossRef
189.
Zurück zum Zitat Torma H, Karlsson T, Michaelsson G, Rollman O, Vahlquist A. Decreased mRNA levels of retinoic acid receptor alpha, retinoid X receptor alpha and thyroid hormone receptor alpha in lesional psoriatic skin. Acta Derm Venereol. 2000;80:4–9.CrossRefPubMed Torma H, Karlsson T, Michaelsson G, Rollman O, Vahlquist A. Decreased mRNA levels of retinoic acid receptor alpha, retinoid X receptor alpha and thyroid hormone receptor alpha in lesional psoriatic skin. Acta Derm Venereol. 2000;80:4–9.CrossRefPubMed
190.
Zurück zum Zitat Billoni N, Buan B, Gautier B, Gaillard O, Mahe YF, Bernhard BA. Thyroid hormone receptor β1 is expressed in the human hair follicle. Br J Dermatol. 2000;142:645–52.CrossRefPubMed Billoni N, Buan B, Gautier B, Gaillard O, Mahe YF, Bernhard BA. Thyroid hormone receptor β1 is expressed in the human hair follicle. Br J Dermatol. 2000;142:645–52.CrossRefPubMed
191.
Zurück zum Zitat Dentice M, Luongo C, Huang S, Ambrosio R, Elefante A, Mirebeau-Prunier D, et al. Sonic hedgehog-induced type 3 deiodinase blocks thyroid hormone action enhancing proliferation of normal and malignant keratinocytes. Proc Natl Acad Sci USA. 2007;104:14466–71. Dentice M, Luongo C, Huang S, Ambrosio R, Elefante A, Mirebeau-Prunier D, et al. Sonic hedgehog-induced type 3 deiodinase blocks thyroid hormone action enhancing proliferation of normal and malignant keratinocytes. Proc Natl Acad Sci USA. 2007;104:14466–71.
Metadaten
Titel
Thyroid diseases and skin autoimmunity
verfasst von
Enke Baldini
Teresa Odorisio
Chiara Tuccilli
Severino Persechino
Salvatore Sorrenti
Antonio Catania
Daniele Pironi
Giovanni Carbotta
Laura Giacomelli
Stefano Arcieri
Massimo Vergine
Massimo Monti
Salvatore Ulisse
Publikationsdatum
15.06.2018
Verlag
Springer US
Erschienen in
Reviews in Endocrine and Metabolic Disorders / Ausgabe 4/2018
Print ISSN: 1389-9155
Elektronische ISSN: 1573-2606
DOI
https://doi.org/10.1007/s11154-018-9450-7

Weitere Artikel der Ausgabe 4/2018

Reviews in Endocrine and Metabolic Disorders 4/2018 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.